BrainStorm
Subscribe on your favorite player
Listen on Apple Podcasts Listen on Spotify Listen on Stitcher Listen on Google PodcastsJohn Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs
![](/sites/default/files/styles/large/public/2021-11/UsA2_BrainStorm%20Podcast_September%2013%202021.jpg?h=7b87a11b&itok=AVmsdf9h)
John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs
Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.
This episode is sponsored by Genentech and Eisai.
![](/sites/default/files/styles/large/public/2021-11/UsA2_BrainStorm%20Podcast_September%2013%202021.jpg?h=7b87a11b&itok=AVmsdf9h)
About This Episode
Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.